RT @InnovOncology: First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocy…
255,577 followers
88,414 followers
RT @InnovOncology: First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocy…
2,905 followers
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma @CD_AACR @OncBrothers @OncoAlert @oncodaily #AACR24 #AACR2024 @TaliLev123 @ElizSMcKenna h
59 followers
Great clinical study from Dr. Woyach and Dr. Byrd for reversible Btk inhibitor. Miss PhD time at OSU learning BTK inhibitor stories